News from hospira, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2015, 07:30 ET

Hospira Reports Second-Quarter 2015 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Jul 16, 2015, 15:59 ET

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Jul 15, 2015, 16:03 ET

Hospira to Announce Second-Quarter 2015 Results on July 29, 2015

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Jun 10, 2015, 03:00 ET

New results from first real-world study show comparable effectiveness and safety of Hospira's Inflectra™ (infliximab) in patients with rheumatic diseases switched from reference infliximab, Remicade™

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars, today announced the results of an independent clinical study, showing...

Jun 02, 2015, 10:00 ET

ANVISA Approves First Infliximab Biosimilar in Brazil

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars, today announced that its partner, Celltrion – a global biopharmaceutical...

May 20, 2015, 09:00 ET

Hospira, Alliance for Health Reform Bring Food and Drug Administration, Industry Experts Together to Discuss the Future of Biosimilars in the United States

 Hospira, Inc. (NYSE: HSP) joined forces with the Alliance for Health Reform and Amgen to bring the U.S. Food and Drug Administration (FDA) and...

May 13, 2015, 13:40 ET

Hospira Shareholders Approve Merger of Hospira and Pfizer at Special Meeting

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Apr 28, 2015, 07:30 ET

Hospira Reports First-Quarter 2015 Results

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Apr 25, 2015, 06:25 ET

Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation

- Hospira fordert die fortdauernde Unterstützung des Extrapolations-Prinzips, um verstärkten Zugang von Patienten zu lebensrettenden...

Apr 25, 2015, 04:40 ET

La direction de Hospira fait une présentation à un forum européen prééminent sur les biosimilaires et annonce un nouveau livre blanc sur l'extrapolation

- Hospira appelle à un soutien continu du principe de l'extrapolation afin de promouvoir l'accès des patients à des médicaments...

Apr 24, 2015, 07:41 ET

Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation

Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, spoke about the importance of extrapolation in bringing...

Apr 13, 2015, 08:30 ET

Esperanza para un acceso mejor de los pacientes a los medicamentos biosimilares

Hospira, Inc. (NYSE: HSP), principal proveedor mundial de fármacos inyectables y tecnologías de infusión, además de líder...

Apr 13, 2015, 03:30 ET

Les patients pourraient bénéficier d'un meilleur accès aux médicaments biosimilaires

Hospira, Inc. (NYSE : HSP), le plus grand fournisseur mondial de médicaments injectables et de technologies d'infusion, et leader mondial...

Apr 13, 2015, 03:30 ET

Hoffnung für besseren Zugriff der Patienten auf biosimilare Medikamente

Hospira, Inc. (NYSE: HSP),der weltweit führende Anbieter von injizierbaren Arzneistoffen und Infusionstechnologien und ein globaler...

Apr 13, 2015, 03:30 ET

Hope for Greater Access for Patients to Biosimilar Medicines

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, said at...

Apr 07, 2015, 16:30 ET

Hospira to Announce First-Quarter 2015 Results on April 28, 2015

 Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars,...

Mar 30, 2015, 11:30 ET

Hospira's INFLECTRA™ (Infliximab) Now Available in Canada

-- Subsequent entry biologic (SEB) medicine provides a lower-cost, high-quality, safe and effective therapy for rheumatoid arthritis (RA),...

Mar 27, 2015, 09:00 ET

Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen

 Hospira, Inc. (NYSE: HSP), a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies,...